Incredibly proud to be with Bishai Lab representing the JHU TB Center Johns Hopkins Medicine at Keystone Symposia Tuberculosis this year #mycobacteria #KSTuberculosis24

First time attending Keystone Symposia and could be more satisfied with the views! #KSTuberculosis24 #TBResearch #mycobacteria

2 years of work resumed in posters! Is amazing everything one can achieve and learn with the help of amazing colleagues and mentors

Great work Xue Chen and Medha Singh for your nice presentations today at JohnsHopkinsTRAC Annual Meeting, and many congrats to Xue for winning The Dannenberg Award!

Not me trying to have a contamination #tuberculosis control plate with my initials on it

Excited to share our latest publication “Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs”. Grateful to my amazing co-authors and mentors 🎉. Check it out here: nature.com/articles/s4146…

Thrilled to share that our 18F-fluorocellobiose paper for specific imaging of Aspergillus infections is now out in Science Translational Medicine. Wonderful team work from the intramural NIH program! @NIHRadiology NIH Clinical Center @nih_nhlbi NIAID News science.org/doi/10.1126/sc…

Nothing like a slice of cake to celebrate a new research milestone! Here’s to many more achievements ahead 🎂 nature.com/articles/s4146…

🚨Nuevo artículo: la meningitis tuberculosa es una de las principales causas de mortalidad extra pulmonar. Proponemos nuevos regímenes de tratamiento, con mejor penetración en el sistema nervioso, están detallados en: nature.com/articles/s4146…

Happy Halloween! Just like my P value of 0.051, I’m haunting the line between spooky and significant! 🎃👻 #HalloweenStats

We love to see everyone #StandUpForScience!

On #WorldTBDay, we highlight the fight against tuberculosis, a preventable and treatable disease that still claims millions of lives. Research, innovation, and access to care are key to #EndTB 🔬🌍

🚨 New from 🐢🐢🐢John Green🐢🐢🐢: Everything Is Tuberculosis 📖🩻 A powerful exploration of TB’s impact on global health, history, and humanity. A must-read for anyone invested in the fight to #EndTB! So grateful with JohnsHopkinsTRAC for this copy #WorldTBDay

Host-directed therapy breakthrough! Navitoclax, a Bcl-2 inhibitor, improves pulmonary TB treatment by promoting bacterial clearance, reducing tissue necrosis, and preventing fibrosis. A potential game changer for post-TB lung disease! Read more in: nature.com/articles/s4146…

🚨 New study out in ATS Blue Journal: PET imaging can distinguish Mycobacteroides abscessus infection from sterile inflammation—offering a noninvasive diagnostic tool for vulnerable patients with underlying lung disease 🔗 atsjournals.org/doi/full/10.11…

🚨New paper out! We demonstrate that 18F-FDS PET enables noninvasive, whole-body detection of invasive mold infections. A step forward in diagnosing life-threatening fungal disease 🔗 nature.com/articles/s4146…

Thrilled to be a co-author on our latest work in Nature Communications! We show how ¹⁸F-FDS PET can noninvasively detect and localize invasive mold infections—even when other methods fail. 🧠🫁 A step forward for immunocompromised patient care. 🔗 nature.com/articles/s4146…

Novel Bacteria-Specific PET Imaging Approach Detects Hard-to-Diagnose Lung Infections Yuderleys Masias-Leon, MD jnm.snmjournals.org/content/66/sup…

Excited to be in Alaska for #WMIC2025! Even more thrilled to kick it off under the magic of the Northern Lights 🌌

A heartfelt thanks to the organizers and peers at #WMIC2025. Presenting our research on molecular imaging for infectious diseases was both an honor and a reminder of the importance of collaboration in advancing global health